Brentuximab vedotin as a bridge to allogeneic stem-cell transplantation for refractory or relapsing patients with CD30 positive anaplastic or T-cell non-Hodgkin lymphomas: a study on behalf of the SFGM-TC
2019
Brentuximab vedotin (BV) is an antibody–drug conjugate (ADC) composed of a CD30-directed monoclonal antibody covalently linked to the anti-microtubule agent monomethyl auristatin E (MMAE). Binding ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
15
References
5
Citations
NaN
KQI